| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 262,768 | 266,524 | 271,060 | 308,114 | | Cost of Revenue | 79,410 | 77,220 | 84,165 | 92,546 | | | Gross Profit | 183,358 | 189,304 | 186,895 | 215,568 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 16,522 | 16,807 | 16,636 | 45,306 | | Non Recurring | 1,143 | 7,706 |
-
|
-
| | Others | 71,261 | 75,793 | 78,311 | 85,144 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 95,575 | 96,704 | 91,948 | 85,118 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,781 | 9,140 | (6,264) | (8,182) | | Earnings Before Interest And Taxes | 98,356 | 104,913 | 86,615 | 66,654 | | Interest Expense | 71,120 | 72,842 | 71,885 | 79,473 | | Income Before Tax | 27,236 | 32,071 | 14,730 | (12,819) | | Income Tax Expense | (1,358) | 152 | 603 | 738 | | Minority Interest | (11,255) | (19,126) |
-
| 1,690 | | | | Net Income From Continuing Ops | 27,722 | 25,206 | 14,730 | (62) | | | Non-recurring Events | | Discontinued Operations | 122 | 74 | (126) | (4,538) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 16,589 | 6,154 | 14,604 | (4,600) | | Preferred Stock And Other Adjustments | (5,455) | 1,983 | (12,892) | (5,455) | | | Net Income Applicable To Common Shares | $11,134 | $8,137 | $1,712 | ($10,055) |
|
0.18% Nasdaq 
Income Statement
